In a recent communication to Congress, U.S. President Donald Trump has called on Mexico to intensify its fight against drug trafficking and associated criminal organizations. The presidential determination, aimed at fiscal year 2027, urges Mexican authorities to not only continue their current efforts but also expand their focus to include the investigation and prosecution of public officials suspected of aiding drug cartels.
Trump acknowledged the steps already taken by Mexican President Claudia Sheinbaum’s administration, such as significant drug seizures and the dismantling of numerous clandestine laboratories. Additionally, he noted the increased deployment of security forces as a positive measure. Despite these efforts, Trump emphasized the need for Mexico to further disrupt the financial networks and organizational structures of drug-trafficking groups.
The document also highlights Mexico and Canada as major drug-transit countries, reflecting the ongoing security concerns between the United States and its neighboring nations. The determination identifies various other countries in the Americas as part of the broader international drug-trafficking routes, underscoring the complexity of the issue.
This call for action comes amidst heightened scrutiny over Mexico’s role in curbing the flow of illegal drugs into the United States, a persistent concern for Washington. Trump’s statement serves as a reminder of the critical importance of international cooperation in addressing drug-related challenges, particularly in regions directly linked to the U.S. drug market.